A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer

B‐cell translocation gene 2 (BTG2) is a tumour suppressor protein known to be downregulated in several types of cancer. In this study, we investigated a potential role for BTG2 in early‐stage non‐small cell lung cancer (NSCLC) survival. We analysed BTG2 methylation data from 1230 early‐stage NSCLC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Sipeng, Zhang, Ruyang, Guo, Yichen, Loehrer, Elizabeth, Wei, Yongyue, Zhu, Ying, Yuan, Qianyu, Moran, Sebastian, Fleischer, Thomas, Bjaanæs, Maria M., Karlsson, Anna, Planck, Maria, Staaf, Johan, Helland, Åslaug, Esteller, Manel, Su, Li, Chen, Feng, Christiani, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983115/
https://www.ncbi.nlm.nih.gov/pubmed/29656435
http://dx.doi.org/10.1002/1878-0261.12204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983115/
https://www.ncbi.nlm.nih.gov/pubmed/29656435
http://dx.doi.org/10.1002/1878-0261.12204

Ejemplares similares